Literature DB >> 1486889

Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosa.

D J Hardy1, A L Barry, P C Fuchs, E H Gerlach, J C McLaughlin, M A Pfaller.   

Abstract

In a collaborative study involving five medical centers, 6% of 2,440 consecutive isolates of Enterobacteriaceae were resistant to cefoperazone; resistance to cefoperazone was reduced to < 1% by the addition of sulbactam. Susceptibility to cefoperazone and cefoperazone-sulbactam was accurately predicted by disk diffusion tests. Resistance to cefoperazone, however, was not as reliably detected by disk tests and results of dilution tests were not always consistent. The prevalence of resistance to cefoperazone and/or the ability to detect resistance had a significant influence on very major error rates for individual laboratories.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486889     DOI: 10.1007/bf01962376

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  6 in total

1.  Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae.

Authors:  A L Barry; P C Fuchs; E H Gerlach; D J Hardy; J C McLaughlin; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.

Authors:  A L Barry; R N Jones
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

3.  In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.

Authors:  R N Jones; A L Barry; R R Packer; W W Gregory; C Thornsberry
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

4.  The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.

Authors:  R N Jones; A L Barry; C Thornsberry; H W Wilson
Journal:  Am J Clin Pathol       Date:  1985-10       Impact factor: 2.493

5.  Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.

Authors:  R N Jones; T L Gavan; A L Barry; C Thornsberry; D L Gibbs
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

6.  Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone.

Authors:  C Thornsberry; A L Barry; R N Jones; C N Baker; R E Badal
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

  6 in total
  1 in total

1.  Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India.

Authors:  Vikas Gautam; Anjana Thakur; Megha Sharma; Avinash Singh; Shruti Bansal; Aditi Sharma; Arti Kapil; Bimal Kumar Das; Sujatha Sistla; Subhash Chandra Parija; Balaji Veeraraghavan; John Antony Jude Prakash; Kamini Walia; V C Ohri; Pallab Ray
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.